Seraphim Awarded 'Top Performer' in Kiwa PVEL's 2025 PV Module Reliability Scorecard for Sixth Time

Seraphim Awarded 'Top Performer' in Kiwa PVEL's 2025 PV Module Reliability Scorecard for Sixth Time

SHANGHAI, June 11, 2025 /PRNewswire/ -- Recently, Kiwa PV Evolution Labs (Kiwa PVEL), a globally recognized independent testing laboratory, released its 2025 PV Module Reliability Scorecard. Seraphim has again secured the 'Top Performer' title in...

What Holds the Internet Together and Why It's Now at Risk

What Holds the Internet Together and Why It's Now at Risk

A new report from ICANN and the Internet Society details how the Internet Governance Forum has supported a stable and secure Internet—and why that model is now under strain. PRAGUE, June 10, 2025 /PRNewswire/ -- As global discussions intensify...

Jackery Presents Latest Sustainable Energy Solutions at AIA25 Expo

Jackery Presents Latest Sustainable Energy Solutions at AIA25 Expo

BOSTON, June 9, 2025 /PRNewswire/ -- Jackery, a global leader in innovative solar generators and renewable energy solutions, showcased its latest breakthroughs at the AIA25 Expo held in Boston from June 5–6. Featuring its new Essential Home Backup...

Shanghai Electric Showcases Cutting-Edge Green and Smart Technology at Carbon Neutrality Expo 2025, Accelerating the Transition to a Zero-Carbon World

Shanghai Electric Showcases Cutting-Edge Green and Smart Technology at Carbon Neutrality Expo 2025, Accelerating the Transition to a Zero-Carbon World

Shanghai Electric was awarded an ISO certification that empowered a 202,647,002-ton reduction in carbon dioxide emissions in 2024. The Company released a proprietary carbon emission accounting platform to enable industry supply chain partners to...

Xinhua Silk Road: Int'l forum on RCEP local gov't, sister city cooperation opens in E. China's Huangshan

Xinhua Silk Road: Int'l forum on RCEP local gov't, sister city cooperation opens in E. China's Huangshan

BEIJING, June 6, 2025 /PRNewswire/ -- The 2025 RCEP Local Governments and Friendship Cities Cooperation (Huangshan) Forum opened on Thursday in Huangshan City, east China's Anhui Province. Photo shows a signing ceremony during the opening ceremony...

New Policy Brief from the NDC Partnership Guides Countries Toward Tripling Renewable Energy

New Policy Brief from the NDC Partnership Guides Countries Toward Tripling Renewable Energy

The NDC Partnership released a new policy brief today to support policymakers to take steps to integrate renewable energy into national climate pledges. WASHINGTON, June 4, 2025 /PRNewswire/ -- The NDC Partnership mobilized 14 country governments...

ThreatBook Selected in the First-ever Gartner® Magic Quadrant™ for Network Detection and Response (NDR)

ThreatBook Selected in the First-ever Gartner® Magic Quadrant™ for Network Detection and Response (NDR)

BEIJING, June 4, 2025 /PRNewswire/ -- After nearly a year of research and evaluation, Gartner released the first "Magic Quadrant for Network Detection and Response" report on May 29, ThreatBook became the only Chinese company selected. As...

Jenscare released 30-day follow-up results of LuX-Valve Plus TRINITY study and 1-year follow-up results of JensClip TMVr at EuroPCR 2025

Jenscare released 30-day follow-up results of LuX-Valve Plus TRINITY study and 1-year follow-up results of JensClip TMVr at EuroPCR 2025

BEIJING, June 3, 2025 /PRNewswire/ -- Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company, recently released 30-day follow-up results of TRINITY Trial of LuX-Valve Plus, a promising...

Ubiik slashes cost to deploy pLTE networks in NZ with new products

Ubiik slashes cost to deploy pLTE networks in NZ with new products

CHRISTCHURCH, New Zealand, June 3, 2025 /PRNewswire/ -- Ubiik, a leading provider of private LTE networks announced today the release of a new base station and LTE router operating in New Zealand's sub-GHz ISM band (915-928MHz) to support the...

InxMed Announces Promising Phase Ib/II Clinical Data for Ifebemtinib + KRAS G12C inhibitor in KRAS G12C-Mutant Solid Tumors at ASCO 2025

InxMed Announces Promising Phase Ib/II Clinical Data for Ifebemtinib + KRAS G12C inhibitor in KRAS G12C-Mutant Solid Tumors at ASCO 2025

NANJING, China, June 1, 2025 /PRNewswire/ -- InxMed Co., Ltd, a clinical-stage biotechnological company, pioneering therapies to transform cancer treatment, released latest clinical data from a Phase Ib/II clinical trial (NCT06166836; NCT05379946)...

  • 1
  • ...
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • ...
  • 24
  • menu
    menu